Currently, Pfizer Inc [PFE] is trading at $26.65, up 1.33%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PFE shares have gain 4.39% over the last week, with a monthly amount glided 0.79%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Wolfe Research started tracking the stock with Underperform rating on November 15, 2024, and set its price target to $25. Bernstein started tracking the stock assigning a Mkt Perform rating and suggested a price target of $32 on October 17, 2024. Daiwa Securities upgraded its rating to a Outperform. Argus downgraded its rating to Hold for this stock on March 22, 2024. In a note dated February 23, 2024, Guggenheim initiated an Buy rating and provided a target price of $36 on this stock.
This stock has fluctuated between a low of $24.48 and a high of $31.54 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $32.25 within the next 12 months. Pfizer Inc [NYSE: PFE] shares were valued at $26.65 at the most recent close of the market. An investor can expect a potential return of 21.01% based on the average PFE price forecast.
Analyzing the PFE fundamentals
Trailing Twelve Months sales for Pfizer Inc [NYSE:PFE] were 63.63B which represents 24.66% growth. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.23%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.13%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.11 points at the first support level, and at 25.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.97, and for the 2nd resistance point, it is at 27.28.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Pfizer Inc [NYSE:PFE] is 1.00. As well, the Quick Ratio is 0.73. Considering the valuation of this stock, the price to sales ratio is 2.37, the price to book ratio is 1.64 and price to earnings (TTM) ratio is 18.93.
Transactions by insiders
Recent insider trading involved BLAYLOCK RONALD E, Director, that happened on Feb 13 ’25 when 19457.0 shares were purchased. Director, Gottlieb Scott completed a deal on Oct 30 ’24 to buy 1000.0 shares. Meanwhile, SVP & Controller DAMICO JENNIFER B. sold 5154.0 shares on Aug 13 ’24.
